Immunotherapy Now First Line for Esophageal Cancer ...Middle East

Nivolumab (Opdivo) with chemotherapy or in combination with ipilimumab (Yervoy) has been approved by the FDA for first-line use in the treatment of unresectable advanced or metastatic esophageal cancer. FDA Approvals

Hence then, the article about immunotherapy now first line for esophageal cancer was published today ( Monday 30/05/2022 - 10:08 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Immunotherapy Now First Line for Esophageal Cancer )

Also on site :

• Teens arrested after large disturbance, multiple fights at Joliet mall
• Transcript: Bank of America CEO Brian Moynihan on "Face the Nation with Margaret Brennan," Dec. 28, 2025
• Feel Free customers say the kratom drink is making them sick. Toothless FDA rules on dietary supplements are helping it remain a bestseller